Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	853.26	447.42	46.94
Graham Fair Price	31.73	7.56	5.74
PEG	-96.34	0.06	1.55
Price/Book	36.21	4.65	3.41
Price/Cash Flow	-63.29	31.17	-84.89
Prices/Earnings	-30.02	-16.24	23.21
Price/Sales	27.39	9.70	7.62
Price/FCF	-63.29	31.17	-84.89
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	1.44	0.86	0.84
Operating Margin	-60.51	-0.04	0.09
ROA	70.84	-0.02	0.01
ROE	0.04	-0.07	94.66
ROIC	0.17	-0.03	-81.48
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	< 0.005	0.01	-62.09
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-0.45	-1.40	-208.97
EPS QOQ	0.15	-2.87	1813.04
FCF QOQ	-16.50	4.51	-72.64
Revenue QOQ	-0.27	0.01	-95.22
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	0.00	0.00	0.00
Days Sales Outstanding (DSO)	44.31	66.53	50.16
Inventory Turnover	0.00	0.00	0.00
Debt/Capitalization	0.50	0.51	2.68
Quick Ratio	2.20	1.64	-25.48
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	6.31	5.96	-5.58
Cash	7.73	8.46	9.40
Capex	-0.12	-0.12	0.32
Free Cash Flow	-0.25	0.89	250.32
Revenue	2.83	2.85	0.96
Naive Interpretation	member

05 - Per Share Metrics · Best

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	2.27	1.69	-25.29
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-2.58	-31.75	-1129.03
Naive Interpretation	Member

06 - Financial Health · Weak

Rating